Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. I'm Jess Fye. I'm a Senior Biotech Analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Jazz. I'm joined by the company's Chairman and CEO, Bruce Cozadd, who's going to give a presentation. And then we're going to move into Q&A with a couple of other members of management team on stage.
If you are in the room and you want to ask a question, you can raise your hand and someone will bring you a mic or you can always use the portal to send me questions on the iPad up here. So with that, let me turn it over to Bruce.
Thank you, Jess, and thank you all for being here. So the 42nd Annual JPMorgan Healthcare Conference, I've only been at the last 33, so I missed a couple, the last 20 representing Jazz Pharmaceuticals. And I have to say, I'm delighted to be here to give you an update on the accomplishments of the company in 2023, but more
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |